By Patrick Kumakech | Economist |member of the Applied Economics Association Uganda
The recently passed National Drug and Health Products Authority Bill, expected to take
effect in July after Presidential assent, marks a significant shift in Uganda’s regulatory
landscape for the beauty and personal care sector. The Bill introduces broader oversight
powers aimed at strengthening public health protection, consumer safety, and product
quality assurance. However, while the proposed law seeks to address the growing
circulation of harmful and substandard products on the Ugandan market, it has also
sparked widespread debate among manufacturers, importers, private sector actors, and
Members of Parliament regarding its broader economic implications.
No responses yet